Lithium Initiation Protocol for Stable Patients
The recommended initial dosing for lithium in stable patients is 300 mg twice or three times daily, with gradual titration based on serum lithium levels, aiming for a therapeutic range of 0.6-1.2 mEq/L. 1
Initial Dosing Strategy
- Starting dose: 300-450 mg/day (as lithium carbonate) 1, 2
- Administration schedule:
- Age-based adjustments:
- Adults <40 years: 25-35 mmol/day (925-1300 mg)
- Adults 40-60 years: 20-25 mmol/day (740-925 mg)
- Adults >60 years: 15-20 mmol/day (550-740 mg) 5
Titration Protocol
- Week 1-2: Start with 300 mg twice daily or 300 mg three times daily
- Week 2-4: Increase by 300 mg increments every 5-7 days based on serum levels and clinical response
- Target serum level: 0.6-1.2 mEq/L for maintenance therapy 1
- Some experts recommend 0.6-0.8 mEq/L for maintenance
- Higher ranges (0.8-1.2 mEq/L) may be needed for acute treatment 5
Monitoring Schedule
Initial Phase (First Month)
Baseline tests (before starting lithium):
- Complete blood count
- Renal function (creatinine, BUN, eGFR)
- Thyroid function (TSH, free T4)
- Electrolytes
- Pregnancy test (if applicable)
- ECG (especially in patients >40 years or with cardiac risk factors)
Serum lithium levels:
Maintenance Phase
- Serum lithium levels: Every 2 months once stabilized 1
- Renal function: Every 3-6 months
- Thyroid function: Every 6-12 months
- Electrolytes: Every 6 months
- Weight and vital signs: At each visit
Special Considerations
Renal Function
- Lithium is primarily excreted by the kidneys
- Contraindicated in severe renal insufficiency 5
- Reduce dose in patients with mild to moderate renal impairment
- Monitor renal function more frequently in at-risk patients
Elderly Patients
- Start with lower doses (150-300 mg/day)
- More sensitive to lithium's effects and may show toxicity at lower serum levels 1
- May require more frequent monitoring of serum levels
Dosing Schedule Considerations
Once-daily dosing:
Multiple daily dosing:
- May provide more stable serum levels
- May be better during initial titration
- Recommended during acute treatment phase 1
Common Side Effects and Management
Short-term: Tremor, increased thirst, polyuria, nausea, diarrhea
- Management: Dose reduction, divided dosing, or timing adjustment
Long-term: Thyroid dysfunction, renal effects, weight gain
- Management: Regular monitoring and appropriate interventions
Important Precautions
- Maintain adequate hydration and normal salt intake
- Temporarily suspend during acute illness, surgery, or severe dehydration
- Avoid NSAIDs as they can increase lithium levels 7
- Educate patients about signs of lithium toxicity (confusion, ataxia, severe tremor)
- Consider drug interactions that may affect lithium levels
By following this structured approach to lithium initiation and monitoring, clinicians can optimize treatment efficacy while minimizing the risk of adverse effects in stable patients requiring lithium therapy.